Hepatitis C Test: Antibody Screening and RNA Confirmation

What Is Hepatitis C?

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It spreads through blood, most often through sharing injection equipment, and less often through sex, childbirth, or needlestick injuries. Unlike hepatitis A and B, there is no vaccine for hepatitis C. The good news is that modern direct-acting antivirals cure most infections in 8 to 12 weeks. This is educational information, not medical advice.

Most new infections become chronic, meaning the virus persists beyond 6 months. Chronic infection slowly scars the liver over decades and can lead to cirrhosis, liver failure, and liver cancer. Because that damage is silent for a long time, screening catches infections that symptoms miss.

Transmission and Symptoms

Blood-to-blood contact drives most transmission. Key risk factors include injection drug use, transfusions or organ transplants before 1992, long-term dialysis, needlestick injuries in health care, and being born to a mother with hepatitis C. Sexual transmission occurs but is less efficient than for HIV or hepatitis B, with higher risk when blood is present or among people with HIV.

• Most people have no symptoms for years or decades
• Fatigue, nausea, or abdominal discomfort when symptoms occur
• Dark urine, pale stool, or yellowing of skin and eyes during flares
• Abnormal liver enzymes (ALT and AST) found on routine blood work
• Signs of advanced liver disease such as swelling or easy bleeding, years later

Guidelines now recommend at least one-time hepatitis C screening for all adults, plus periodic testing for people with ongoing risk. Pregnant people are also routinely screened, since treatment timing around pregnancy needs planning.

How Hepatitis C Testing Works

Testing happens in two steps. First, an HCV antibody test checks whether you were ever exposed. It uses a standard blood draw and is inexpensive and widely available. If the antibody test is negative, no further hepatitis C testing is needed unless exposure was very recent or ongoing.

If the antibody test is positive, a second test called an HCV RNA test (NAAT) checks whether viral genetic material is present right now. This distinction matters because a meaningful share of people clear the virus spontaneously yet keep antibodies for life. Only RNA confirms current infection that needs treatment. Some labs run automatic reflex RNA testing on the same sample when the antibody is positive, which saves a second blood draw.

Window Period and Accuracy

Antibodies take weeks to appear. HCV RNA can often be detected 1 to 2 weeks after exposure, while antibodies commonly take 8 to 11 weeks. If exposure was within the past few weeks and the antibody screen is negative, RNA testing or repeat antibody testing after the window gives a firmer answer.

Both methods are highly accurate when timed correctly. False negatives come mostly from testing too early. False positive antibody screens are uncommon but possible, which is another reason RNA confirmation is required before treatment decisions.

How to Order and Where to Get Tested

Direct-access screening starts with the antibody test. You order online, visit a local lab for a blood draw, and receive results in a secure portal, usually within 1 to 3 business days. If the antibody is positive, the lab may automatically run RNA on the same sample, or you will be directed to order RNA confirmation and see a clinician for staging.

Results are confidential and go directly to you. A positive RNA result should lead promptly to medical care for liver assessment and antiviral treatment, which is well tolerated and highly effective. Tell people who may share blood exposure risk, such as injection partners, so they can test as well.

How Much Does It Cost

Self-pay hepatitis C antibody screening commonly costs about 50 to 120 dollars. RNA confirmation costs more, often in the low hundreds, because it uses molecular methods. Combination hepatitis A, B, and C panels bundle screening at a lower per-test price than ordering each separately.

Insurance usually covers guideline-based screening for adults and pregnant people. Public health clinics often provide low-cost or free hepatitis C screening for people with high risk or limited income. Treatment itself is expensive at list price but is widely covered by insurance and assistance programs once infection is confirmed.